Brainsway (BRSYF) Other Non-Current Assets (2018 - 2026)
Brainsway's (BRSYF) quarterly Other Non-Current Assets came in at $2.2 million in Q2 2026, down 44.54% on a YoY basis from $3.9 million in Q2 2025, and down 6.2% quarter-over-quarter from $2.3 million in Q1 2026.
Analysis
Brainsway (BRSYF) Other Non-Current Assets (2018 - 2026) Analysis & Trends
Brainsway (BRSYF) has reported Other Non-Current Assets for 9 consecutive years, with $2.2 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Other Non-Current Assets fell 44.54% year-over-year to $2.2 million; the trailing twelve-month figure through Jun 2026 stood at $2.2 million (down 44.54% YoY), and the FY2025 full-year result was $1.9 million, down 28.43% from the prior year.
- Other Non-Current Assets declined to $2.2 million in Q2 2026 per BRSYF's latest filing, from $2.3 million in the prior quarter.
- Across five years, Other Non-Current Assets topped out at $3.9 million in Q2 2025 and bottomed at $863000.0 in Q3 2022.
- Historically, Other Non-Current Assets has averaged $2.0 million across 5 years, with a median of $1.9 million in 2024.
- The sharpest annual moves came in 2022 and 2026: Other Non-Current Assets soared 498.18% in 2022, then plunged 44.54% in 2026.
- Over 5 years, Other Non-Current Assets stood at $1.0 million in 2022, then surged by 64.78% to $1.7 million in 2023, then surged by 57.13% to $2.7 million in 2024, then slipped by 28.43% to $1.9 million in 2025, then rose by 12.01% to $2.2 million in 2026.
- According to Business Quant data, Other Non-Current Assets over the past three periods registered $2.2 million, $2.3 million, and $1.9 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.19 Bn | 175.58 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 127.77 Bn | 122.55 Bn | 1.96 Bn | - |
| 3 | Medtronic | 117.13 Bn | 108.31 Bn | 6.34 Bn | 4.32 Bn |
| 4 | Stryker | 104.67 Bn | 101.20 Bn | 4.50 Bn | 3.23 Bn |
| 5 | Boston Scientific | 64.48 Bn | 63.94 Bn | 3.85 Bn | 45.22 Bn |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn | 616.40 Mn |
| 7 | Alcon | 33.06 Bn | 31.61 Bn | 1.68 Bn | 434.00 Mn |
| 8 | Dexcom | 32.37 Bn | 30.43 Bn | 830.00 Mn | 273.70 Mn |
| 9 | Steris | 20.76 Bn | 20.28 Bn | 684.20 Mn | 215.10 Mn |
| 10 | Brainsway | 592.58 Mn | 529.41 Mn | 12.77 Mn | 2.16 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.16 Mn |
| Mar 31, 2026 | 2.31 Mn |
| Dec 31, 2025 | 1.93 Mn |
| Sep 30, 2025 | 3.55 Mn |
| Jun 30, 2025 | 3.90 Mn |
| Mar 31, 2025 | 3.30 Mn |
| Dec 31, 2024 | 2.70 Mn |
| Sep 30, 2024 | 2.27 Mn |
| Jun 30, 2024 | 2.05 Mn |
| Mar 31, 2024 | 1.88 Mn |
| Dec 31, 2023 | 1.72 Mn |
| Sep 30, 2023 | 1.40 Mn |
| Jun 30, 2023 | 1.22 Mn |
| Mar 31, 2023 | 1.06 Mn |
| Dec 31, 2022 | 1.04 Mn |
| Sep 30, 2022 | 863,000.00 |
| Jun 30, 2022 | 999,000.00 |
| Mar 31, 2022 | 987,000.00 |
| Dec 31, 2021 | 954,000.00 |
| Sep 30, 2021 | 175,000.00 |